View in EDS

Add-on histamine receptor-3 antagonist for allergic rhinitis: a double blind randomized crossover trial using the environmental exposure unit.

Saved in:
Bibliographic Details
Title: Add-on histamine receptor-3 antagonist for allergic rhinitis: a double blind randomized crossover trial using the environmental exposure unit.
Authors: North ML; Department of Biomedical and Molecular Sciences, Queen's University, Kingston, Ontario, Canada ; Allergy Research Unit, Kingston General Hospital, Kingston, Ontario, Canada., Walker TJ; Allergy Research Unit, Kingston General Hospital, Kingston, Ontario, Canada., Steacy LM; Allergy Research Unit, Kingston General Hospital, Kingston, Ontario, Canada., Hobsbawn BG; Allergy Research Unit, Kingston General Hospital, Kingston, Ontario, Canada., Allan RJ; Pfizer Ltd., Sandwich, UK., Hackman F; Pfizer Ltd., Sandwich, UK., Sun X; Clinical Research Centre, Kingston General Hospital, Kingston, Ontario, Canada., Day AG; Clinical Research Centre, Kingston General Hospital, Kingston, Ontario, Canada., Ellis AK; Department of Biomedical and Molecular Sciences, Queen's University, Kingston, Ontario, Canada ; Allergy Research Unit, Kingston General Hospital, Kingston, Ontario, Canada ; Division of Allergy and Immunology, Department of Medicine, Queen's University, Doran 1, Kingston General Hospital, 76 Stuart Street, Kingston, ON K7L 2 V7, Canada.
Source: Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology [Allergy Asthma Clin Immunol] 2014 Jul 03; Vol. 10 (1), pp. 33. Date of Electronic Publication: 2014 Jul 03 (Print Publication: 2014).
Publication Type: Journal Article
Journal Info: Publisher: Country of Publication: England NLM ID: 101244313 Publication Model: eCollection Cited Medium: Print ISSN: 1710-1484 (Print) Linking ISSN: 17101484 NLM ISO Abbreviation: Allergy Asthma Clin Immunol Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1710-1484
DOI:10.1186/1710-1492-10-33